Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Dinaz Irani"'
Ethical Dilemmas in Palliative Care: Treating Cancer in Patients with Serious Mental Illness (CS324)
Publikováno v:
Journal of Pain and Symptom Management. 65:e551-e552
Publikováno v:
Journal of Endocrinological Investigation. 36:1121-1127
Hypoparathyroidism is a disorder characterized by hypocalcemia, deficient PTH, and abnormal bone remodeling. Standard treatment of hypoparathyroidism consists of oral calcium and vitamin D supplementation. However, maintaining serum calcium levels ca
Autor:
Elizabeth Shane, Serge Cremers, Ivelisse Colon, Donald J. McMahon, David C. Ferris, Michael T. Yin, Dinaz Irani, Chiyuan A. Zhang
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:554-562
The objective of the study was to assess the effects of HIV infection and antiretroviral therapy on change in bone mineral density (BMD) in postmenopausal minority women.We report a longitudinal analysis of change in BMD with a median duration of 15.
Autor:
Lois Brafman, Elizabeth Shane, Katherine D. Crew, Gina Cucchiara, Donald J. McMahon, Serge Cremers, Dawn L. Hershman, Dinaz Irani
Publikováno v:
Journal of Clinical Oncology. 26:4739-4745
Purpose Adjuvant chemotherapy for breast cancer (BC) may be associated with increased rates of bone loss and decreased bone mineral density (BMD) and may lead to premature osteoporosis and increased fracture risk. We examined whether zoledronic acid
Publikováno v:
Medical Hypotheses. 60:915-923
Chronic fatigue syndrome (CFS) is complex illness with unknown aetiology. Recent research shows that patients with CFS have marked alterations in microbial flora, including lowered levels of bifidobacteria and small intestinal bacterial overgrowth (S
Autor:
Chiyuan Zhang, John P. Bilezikian, Laura Anderson, Dinaz Irani, Elizabeth Levy, Natalie E. Cusano, Aline G. Costa, Mishaela R. Rubin
Context:We previously reported on four patients treated with PTH(1–84) who recovered from postoperative hypoparathyroidism many years after onset. Because vascular endothelial growth factor (VEGF) has been shown to be necessary for the induction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb15458b50dc967e7571732085b0727
https://europepmc.org/articles/PMC4184068/
https://europepmc.org/articles/PMC4184068/
Autor:
Laura Anderson, John P. Bilezikian, Natalie E. Cusano, Elizabeth Levy, Mishaela R. Rubin, Donald J. McMahon, Dinaz Irani
In hypoparathyroidism, quality of life (QOL) is compromised as compared to normal subjects. We previously reported our results showing an association with recombinant human PTH(1-84) therapy in hypoparathyroidism and improvement in QOL measures for 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c55a244fc2329ca78cacd44e3cb01f
https://europepmc.org/articles/PMC4184077/
https://europepmc.org/articles/PMC4184077/
Autor:
Dinaz Irani, Mishaela R. Rubin, Laura Anderson, Natalie E. Cusano, James Sliney, John P. Bilezikian, Barbara C. Silva, Aline G. Costa
Publikováno v:
The Journal of clinical endocrinology and metabolism. 98(11)
Transient and permanent postoperative hypoparathyroidism are recognized complications of neck surgery. Postoperative hypoparathyroidism is usually considered permanent when it persists for 6 months; in rare cases, recovery of hypoparathyroidism throu
Autor:
Amanda Tulley, Mishaela R. Rubin, John P. Bilezikian, Natalie E. Cusano, Dinaz Irani, James Sliney, Donald J. McMahon
Publikováno v:
The Journal of clinical endocrinology and metabolism. 98(6)
Complaints from hypoparathyroid patients often reflect a reduction in quality of life (QOL), yet few data exist characterizing these complaints or the potential effects of PTH therapy to ameliorate them.We tested the hypothesis that PTH(1-84) therapy
Autor:
Ego Seeman, Stephanie Boutroy, George Jerums, Dinaz Irani, Thuy D.T. Vu, Xiaofang Wang, Qingju Wang, Roger Zebaze, Ali Ghasem-Zadeh, Barbara C. Silva, John P. Bilezikian, Megan E. Romano, Julia Udesky, Natalie E. Cusano
In primary hyperparathyroidism (PHPT), protracted elevation of serum parathyroid hormone (PTH) is held to be associated with cortical, but not trabecular, bone loss. However, an alternative explanation for the apparent preservation of trabecular bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb335d26ac1b1eab0031dfa1c1ef350
https://europepmc.org/articles/PMC4308951/
https://europepmc.org/articles/PMC4308951/